What is Avenue Therapeutics Inc?
, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; and intravenous tramadol for the treatment of post-operative acute pain. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.81M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.